Cangrelor Tetrasodium

Preferred Label : Cangrelor Tetrasodium;

NCIt definition : The tetrasodium salt form of cangrelor, an inhibitor of the platelet adenosine diphosphate (ADP) P2Y12 receptor (P2Y12R), with antiplatelet activity. Upon administration, cangrelor selectively and reversibly binds to P2Y12R, and blocks the platelet signaling pathway. This inhibits the activation of the glycoprotein complex GPIIb/IIIa, fibrinogen binding to platelets and platelet adhesion and aggregation.;

UNII : 2144G00Y7W;

InChIKey : COWWROCHWNGJHQ-OPKBHZIBSA-J;

CAS number : 163706-36-3;

Drug name : Kengreal;

Chemical formula : C17H21Cl2F3N5O12P3S2.4Na;

Details

Origin ID

C76396;

UMLS CUI

C2698975;

Currated CISMeF NLP mapping
- CANGRELOR TETRASODIUM [Drug component]
- Cangrelor tetrasodium [SMS substance]
- Cangrelor tetrasodium (substance) [SNOMED CT concept]
- cangrelor tetrasodium [MeSH concept]
Manual NTBT mappings (CISMeF)
- Cangrelor (substance) [SNOMED CT concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- CANGRELOR TETRASODIUM [Drug component]
- Cangrelor tetrasodium (substance) [SNOMED CT concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
has_free_acid_or_base_form
- Cangrelor [NCIt concept]
is_salt_form_of
- Cangrelor [NCIt concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients